Tirzepatide Monthly Program
$279.00
- Description
Tirzepatide (GLP-2)
Dual agonist therapy for superior weight loss outcomes
A dual GIP and GLP-1 receptor agonist targeting two separate metabolic pathways simultaneously. Clinical trials demonstrated average weight reductions of 20 to 22 percent of body weight, outperforming single agonist therapies.
Key Benefits
- Dual receptor activation for superior weight loss
- Greater appetite suppression than single agonist therapy
- Improves insulin sensitivity and blood sugar control
- Clinical data showing 20 to 22 percent average weight reduction
Protocol
| Frequency | Dose | Cycle |
|---|---|---|
| Once / week | Titrated | Ongoing |
Pricing
|
Monthly Starter $279 Flexible supply |
Monthly Maintenance $799 Monthly maintenance |
12 Week Package $2,499 No auto-renewal |
Administration Instructions:
